The Impact of Components on Drug Quality and Risk Mitigation

Discusses the need for technology investments, more robust control strategies and next generation elastomer components to provide superior products.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety.

Please Signup/Login to see the full article.